Pharmacology at Penn State College of Medicine
The Department of Pharmacology will provide high quality training of the next generation of scientists and physicians and develop new diagnostic tests, medicines and delivery systems.
The Department of Pharmacology at Penn State College of Medicine is committed to teaching and research in the biomedical sciences. The department occupies 20,000 square of new laboratory space (all built since 2007) in the Hershey Center for Applied Research, the Penn State Cancer Institute, and the Institute for Personalized Medicine. Research ranges from cell and molecular studies of cancer to biochemical/ pharmacological investigation of nervous system function (neurodegenerative disease, cognition and substance abuse) to whole animal studies of drug development.
Educationally, the department is involved in medical, graduate, and allied health instruction and training. Former PhD trainees of the department are currently employed as professors, entrepreneurs, research scientists, and administrators throughout the world. Our faculty serve as educational leaders within the university and across the nation. We are assistant deans, course directors, textbook authors, and PhD program directors.
This is an exciting time in biomedical research and teaching. Join us for graduate school, for a postdoctoral position, as a faculty member. We Are... Penn State Pharmacology.
Kent Vrana, PhD
Pharmacology Department Chair
Penn State College of Medicine
More about Pharmacology @ Penn State
Latest from Pharmacology
- ASR352, A potent anticancer agent: Synthesis, preliminary SAR, and biological activities against colorectal cancer bulk, 5-fluorouracil/oxaliplatin resistant and stem cells.Narayan S, Ramisetti S, Jaiswal AS, Law BK, Singh-Pillay A, Singh P, Amin S, Sharma AK. Eur J Med Chem 2019 Jan 1;161:456-467
- Aldehyde dehydrogenase in regulatory T-cell development, immunity and cancer.Bazewicz CG, Dinavahi SS, Schell TD, Robertson GP. Immunology 2019 Jan;156(1):47-55 Review.
- Inhibiting geranylgeranyl diphosphate synthesis reduces nuclear androgen receptor signaling and neuroendocrine differentiation in prostate cancer cell models.Weissenrieder JS, Reilly JE, Neighbors JD, Hohl RJ. Prostate 2019 Jan;79(1):21-30
- D1 dopamine receptors intrinsic activity and functional selectivity affect working memory in prefrontal cortex.Yang Y, Lee SM, Imamura F, Gowda K, Amin S, Mailman RB. Mol Psychiatry 2018 Dec 7 [Epub ahead of print]